1994PubMedRequires access

[The managements of nutrition for hepatic cirrhosis].

Tomoyuki Kuroki, S Nishiguchi, Shinya Nakajima, S Shiomi, Hiroyuki Oka, Shigeyoshi Harihara

Open publisher page 0 citations

Abstract

Hepatic cirrhosis is the end stage in chronic liver diseases and this condition cause the patient's death because of hepatic failure. A prognosis of patients with hepatic cirrhosis depend on the liver function, especially the function of mass of residual hepatocytes and this function expressed by level of serum albumin, cholinesterase (Ch E) or ICGR-15. This function is improved a management of nutrition because hepatocytes are regenerate by intake of protein. In compensated hepatic cirrhosis, hepatocytes are regenerate by dietary intake of 100-120 g/day of protein and the function of mass of residual hepatocytes is increased. The prognosis of these patients with compensated hepatic cirrhosis are improved by this management of nutrition.

About this research paper

What this paper is about

Hepatic cirrhosis is the end stage in chronic liver diseases and this condition cause the patient's death because of hepatic failure. A prognosis of patients with hepatic cirrhosis depend on the liver function, especially the function of mass of residual hepatocytes and this function expressed by level of serum albumin, cholinesterase (Ch E) or ICGR-15. This function is improved a management of nutrition because hepatocytes are regenerate by intake of protein. In compensated hepatic cirrhosis, hepatocytes are regenerate by dietary intake of 100-120 g/day of protein and the function of mass of residual hepatocytes is increased. The prognosis of these patients with compensated hepatic cirrhosis are improved by this management of nutrition.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Hepatic cirrhosis is the end stage in chronic liver diseases and this condition cause the patient's death because of hepatic failure. A prognosis of patients with hepatic cirrhosis depend on the liver function, especially the function of mass of residual hepatocytes and this function expressed by level of serum albumin, cholinesterase (Ch E) or ICGR-15. This function is improved a management of nutrition because hepatocytes are regenerate by intake of protein. In compensated hepatic cirrhosis, hepatocytes are regenerate by dietary intake of 100-120 g/day of protein and the function of mass of residual hepatocytes is increased. The prognosis of these patients with compensated hepatic cirrhosis are improved by this management of nutrition.

Key concepts: Cirrhosis, Hepatic function, Liver function, Albumin, Internal medicine, Gastroenterology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[The managements of nutrition for hepatic cirrhosis]. — Research Paper | ScholarLens